India Category archive
Browse every WeightEasy India article in the India Brand Guides category.
Category pages gather broader article themes, which makes them useful for readers who are exploring a whole area like injection routines, side effects, or dose tracking.
If your doctor recently mentioned Obeda, or you have been seeing it pop up in health news, you are not alone. Since India's semaglutide patent expired on March 20, 2026, Obeda has...
Obeda has made headlines since its launch in India and rightly so. But that excitement can lead some people to assume it is for everyone who wants to lose weight. It is not. Obeda...
If your doctor has mentioned Obeda as a weight loss or diabetes treatment option, you are looking at one of the newest GLP 1 medicines to reach Indian pharmacies. Dr. Reddy's Labor...
If your doctor has just prescribed Noveltreat, or you have heard about it and want to know more, you are not alone. A lot of people feel a little confused when they first encounter...
If your doctor has recently prescribed Semaglyn, you may be wondering how this injection works and whether it is right for you. That is completely normal. New medicines can feel co...
Something historic happened in India's pharmaceutical market today. On March 20, 2026, the patent on semaglutide, the active ingredient in Ozempic and Wegovy, expired. Overnight, o...
Generic semaglutide arrived in India on March 20, 2026. Among the 50+ brands entering the market on patent expiry day, Sun Pharma's Sematrinity is the headline launch, and for anyo...